Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02914938
Title A Study of ME-401 in Subjects With CLL/SLL, FL, and B-cell Non Hodgkin's Lymphoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors MEI Pharma, Inc.
Indications

chronic lymphocytic leukemia/small lymphocytic lymphoma

B-cell lymphoma

marginal zone B-cell lymphoma

diffuse large B-cell lymphoma

follicular lymphoma

Therapies

zandelisib

Rituximab + zandelisib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.